GGrantIndex
Sort

130,381 grants matching hiv

Safeguard the Household

$1,170,592
Ian Matthias Sanne · Wits Health Consortium (Pty), Ltd · U19 · FY2007 · AI

Adjuvant Development in the context of a vaccine to protect against tuberculosis

$1,170,507
Nikolai Petrovsky · Vaxine Pty Ltd · N01 · FY2021 · AI

MICROBICIDE DES DEV TEAMS

$1,170,357
Tom McCarthy · Starpharma, Ltd · N01 · FY2009 · AI

TRAINING HIV PROGRAM MANAGERS FOR KENYA

$1,170,000
James Njogu Kiarie · University Of Nairobi · U2G · FY2012 · PS

Strategies to improve the HIV care continuum among key populations in India

$1,169,991
Gregory M Lucas · Johns Hopkins University · R01 · FY2015 · DA

Molecular Epidemiology Studies of Occupational and Environmental Exposures

$1,169,903
Nathaniel Rothman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2025 · CA

UAB AIEDRP: Immune Control and Escape in Acute Infection

$1,169,746
University Of Alabama At Birmingham · U01 · FY2002 · AI

J-RISE: Relevant Implementation Strategies to Eliminate the social and structural barriers to HIV services among Justice-involved Black men who have sex with men

$1,169,627
Russell Brewer · University Of Chicago · R01 · FY2023 · MH

Topical Agents to Prevent Mucosal HIV Transmission

$1,169,561
Case Western Reserve University · P01 · FY2002 · AI

Phase I therapeutic testing of viral-vectored vaccines that shift CD8+ T cell immunodominance to conserved regions of HIV-1

$1,169,548
Nilu Goonetilleke · Univ Of North Carolina Chapel Hill · U01 · FY2018 · AI

Development of Akt Inhibitors

$1,169,414
Phillip A. Dennis · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA

Primate Studies

$1,169,245
Samir Kishor Lakhashe · Texas Biomedical Research Institute · P01 · FY2016 · AI

GENDER EFFECTS ON HIV BIOLOGY

$1,169,192
J. David Gladstone Institutes · P01 · FY2003 · HD

Planning, Implementation and Evaluation of Comprehensive HIV Prevention Programs

$1,169,000
Billy Scott · Population Services International · U2G · FY2015 · GH

Harnessing Highly Networked HLA-E-Restricted CTL Epitopes to Achieve a Broadly Effective HIV Cure

$1,169,000
Gaurav Das Gaiha · Massachusetts General Hospital · DP1 · FY2024 · DA

Harnessing Highly Networked HLA-E-Restricted CTL Epitopes to Achieve a Broadly Effective HIV Cure

$1,169,000
Gaurav Das Gaiha · Massachusetts General Hospital · DP1 · FY2025 · DA

Harnessing Highly Networked HLA-E-Restricted CTL Epitopes to Achieve a Broadly Effective HIV Cure

$1,169,000
Gaurav Das Gaiha · Massachusetts General Hospital · DP1 · FY2023 · DA

National Neurological AIDS Bank

$1,168,985
Elyse J Singer · University Of California Los Angeles · U24 · FY2014 · MH

Towards Treatment of Alzheimer’s Disease by Targeting Pathogenic Tau and Beta-Amyloid Structures

$1,168,683
David Eisenberg · University Of California Los Angeles · R01 · FY2025 · AG

National Neurological AIDS Bank

$1,168,629
Elyse J Singer · University Of California Los Angeles · U24 · FY2016 · MH

Boston Pediatric AIDS Clinical Trials Unit

$1,168,600
Children'S Hospital Boston · U01 · FY2003 · AI

Preclinical Development of HIV-1 Vif Antagonists

$1,168,508
Mario Stevenson · University Of Miami School Of Medicine · P01 · FY2017 · MH

Immunopathogenesis of HIV Neurological Disorders

$1,168,467
University Of Puerto Rico Med Sciences · U54 · FY2002 · NS

IMMUNOLOGY AND MOLECULAR VIROLOGY OF ACUTE HIV INFECTION

$1,167,948
Fred Hutchinson Cancer Research Center · U01 · FY2002 · AI

Identifying Roadblocks to Antigen Expression and Enhancing Killing of HIV-Infected Cells That Are Refractory to Clearance

$1,167,948
Sarah Beth Joseph · Univ Of North Carolina Chapel Hill · R01 · FY2024 · AI